Skip to content

Advertisement

BMC Urology

What do you think about BMC? Take part in

Urological oncology

Section edited by Philippe Spiess, Jose Karam and Chris Protzel

This section considers clinical studies relevant to oncological disorders in urology

Previous Page Page 4 of 8 Next Page
  1. Content type: Research article

    The high false negative rates for initial prostate biopsies refer a large number of the men for repeat biopsies each year. Therefore, biomarkers associated with high risk of the presence of malignancy in histo...

    Authors: Saeid Alinezhad, Riina-Minna Väänänen, Natalia Tong Ochoa, Emily A. Vertosick, Anders Bjartell, Peter J Boström, Pekka Taimen and Kim Pettersson

    Citation: BMC Urology 2016 16:10

    Published on:

  2. Content type: Research article

    Lymphovascular invasion (LVI) is an important step in the process of tumor dissemination and metastasis outside the primary organ, but the relationship between LVI and the prognosis of T1 non-muscle invasive b...

    Authors: Keishiro Fukumoto, Eiji Kikuchi, Shuji Mikami, Akira Miyajima and Mototsugu Oya

    Citation: BMC Urology 2016 16:5

    Published on:

  3. Content type: Research article

    Measurement of the prostate specific antigen (PSA) remains an important tool in prostate cancer (PC) diagnosis. Due to limited availability of laboratory devices in an outpatient setting, compact and easy-to-h...

    Authors: Steffen Rausch, Joerg Hennenlotter, Josef Wiesenreiter, Andrea Hohneder, Julian Heinkele, Christian Schwentner, Arnulf Stenzl and Tilman Todenhöfer

    Citation: BMC Urology 2016 16:4

    Published on:

  4. Content type: Research article

    Current therapies for advanced renal cell carcinoma (RCC) have low cure rates or significant side effects. It has been reported that complexes composed of interleukin (IL)-2 and stimulating anti-IL-2 antibody ...

    Authors: Kyu-Hyun Han, Ki Won Kim, Ji-Jing Yan, Jae-Ghi Lee, Eun Mi Lee, Miyeon Han, Eun Jin Cho, Seong Sik Kang, Hye Jin Lim, Tai Yeon Koo, Curie Ahn and Jaeseok Yang

    Citation: BMC Urology 2016 16:2

    Published on:

  5. Content type: Research article

    The American Urological Association (AUA) changed their Prostate-Specific Antigen (PSA) screening guidelines in 2013 to not recommend testing in men under 55 years of age without significant risk factors (such...

    Authors: Nandu D. Dantanarayana, Tania Hossack, Paul Cozzi, Andrew Brooks, Howard Lau, Warick Delprado and Manish I. Patel

    Citation: BMC Urology 2015 15:124

    Published on:

  6. Content type: Research article

    Prostate cancer is the second most common diagnosed cancer in men. Due to the low specificity of current diagnosis methods for detecting prostate cancer, identification of new biomarkers is highly desirable. T...

    Authors: Jin Huang, Kathleen H. Reilly, Hui-Zhen Zhang and Hai-Bo Wang

    Citation: BMC Urology 2015 15:118

    Published on:

  7. Content type: Research article

    Prostate cancer remains the most common cancer in men. Qualitative or semi-quantitative immunochromatographic measurements of prostate specific antigen (PSA) have been shown to be simple, noninvasive and feasi...

    Authors: Cheng-Ching Wu, Hung-Yu Lin, Chao-Ping Wang, Li-Fen Lu, Teng-Hung Yu, Wei-Chin Hung, Jer-Yiing Houng, Fu-Mei Chung, Yau-Jiunn Lee and Jin-Jia Hu

    Citation: BMC Urology 2015 15:109

    Published on:

  8. Content type: Research article

    To investigate the efficacy of initial biopsy or transurethral resection of bladder tumor for detecting histological variants on radical cystectomy and to assess the prognostic significance of variant histolog...

    Authors: Peng Ge, Zi-Cheng Wang, Xi Yu, Jian Lin and Qun He

    Citation: BMC Urology 2015 15:46

    Published on:

  9. Content type: Research article

    Urothelial carcinoma (UC) is a common cancer affecting many patients in the United States. Nephroureterectomy remains the gold standard for the treatment of high grade upper tract disease or low grade tumors t...

    Authors: Michael A. Moriarty, Matthew A. Uhlman, Megan T. Bing, Michael A. O’Donnell, James A. Brown, Chad R. Tracy, Sundeep Deorah, Kenneth G. Nepple and Amit Gupta

    Citation: BMC Urology 2015 15:45

    Published on:

  10. Content type: Research article

    Adrenocortical carcinoma (ACC) is aggressive, but rare tumours that have not been sufficiently studied. The aim of our study was to present the demographic and clinical characteristics of patients with ACC, to...

    Authors: Zlatibor Loncar, Vladimir Djukic, Vladan Zivaljevic, Tatjana Pekmezovic, Aleksandar Diklic, Svetislav Tatic, Dusko Dundjerovic, Branislav Olujic, Nikola Slijepcevic and Ivan Paunovic

    Citation: BMC Urology 2015 15:43

    Published on:

  11. Content type: Research article

    Clinical benefit of axitinib as a first line agent to treat patients with metastatic renal cell carcinoma (mRCC), or locally advanced renal cell carcinoma (RCC) have not been clearly demonstrated. The aim of t...

    Authors: Takuya Koie, Chikara Ohyama, Takahiro Yoneyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa and Kazuyuki Mori

    Citation: BMC Urology 2015 15:32

    Published on:

  12. Content type: Research article

    This study describes and compares health-related quality of life (HRQOL) of prostate cancer patients who received either radical prostatectomy (nerve-sparing, nsRP, or non-nerve-sparing, nnsRP) or radiotherapy...

    Authors: Nora Eisemann, Sandra Nolte, Maike Schnoor, Alexander Katalinic, Volker Rohde and Annika Waldmann

    Citation: BMC Urology 2015 15:28

    Published on:

  13. Content type: Research article

    Radical prostatectomy is a standard surgical treatment of clinically localized prostate cancer. Margin status has been found to be an independent predictor of biochemical recurrence (BCR) after open radical pr...

    Authors: Ryuta Tanimoto, Yomi Fashola, Kymora B Scotland, Anne E Calvaresi, Leonard G Gomella, Edouard J Trabulsi and Costas D Lallas

    Citation: BMC Urology 2015 15:27

    Published on:

  14. Content type: Research article

    To assess pathological correlations and temporal trends of Angiopoietin-2 (ANGPT2), vascular endothelial growth factor (VEGF) and M2 Pyruvate kinase (TuM2PK), markers of tumor vascular development and metaboli...

    Authors: Bishoy A Gayed, Jessica Gillen, Alana Christie, Samuel Peña-Llopis, Xian-Jin Xie, Jingsheng Yan, Jose A Karam, Ganesh Raj, Arthur I Sagalowsky, Yair Lotan, Vitaly Margulis and James Brugarolas

    Citation: BMC Urology 2015 15:24

    Published on:

  15. Content type: Research article

    Hematuria can be symptomatic of urothelial carcinoma (UC) and ruling out patients with benign causes during primary evaluation is challenging. Patients with hematuria undergoing urological work-ups place signi...

    Authors: Laimonis Kavalieris, Paul J O’Sullivan, James M Suttie, Brent K Pownall, Peter J Gilling, Christophe Chemasle and David G Darling

    Citation: BMC Urology 2015 15:23

    Published on:

  16. Content type: Case report

    Major life-threatening complications secondary to cisplatin-based chemotherapy are rare in patients with testicular germ cell tumour (GCT). The incidence of complications increases with dosage of chemotherapy ...

    Authors: Klaus-Peter Dieckmann, Petra Anheuser, Ralf Gehrckens, Sven Philip Aries, Raphael Ikogho and Wiebke Hollburg

    Citation: BMC Urology 2015 15:21

    Published on:

  17. Content type: Case report

    Metastasis to penis usually arises from genitourinary organs, but in rare cases, metastasis comes from the sigmoid colon. Furthermore, very few cases of penile metastasis of primary sigmoid colon carcinoma hav...

    Authors: Zhengbang Dong, Chao Qin, Qijie Zhang, Lei Zhang, Haijing Yang, Jingdong Zhang and Fei Wang

    Citation: BMC Urology 2015 15:20

    Published on:

Previous Page Page 4 of 8 Next Page